Evgenii Shumilov

Nov 20, 2023 | onlinelibrary.wiley.com | Ulrike Bacher |Evgenii Shumilov |Thomas Pabst

Currently, our understanding is limited regarding the relationship between anti-SARS-CoV-2 antibody levels post-COVID-19 vaccination and their protective value against the B.1.1.529 (Omicron) variant of SARS-CoV-2. In addition, the benefit of mRNA-based COVID-19 vaccines against the Omicron variant in patients with haematological malignancies remains to be clarified. In their paper the authors1 present the results of a prospective study from Lithuania.

Jul 30, 2023 | onlinelibrary.wiley.com | Ulrike Bacher |Evgenii Shumilov |Thomas Pabst |Dell'Eva M

Ulrike Bacher and Evgenii Shumilov contributed equally and should both be considered as first authors. Commentary on: Pinder et al. Humoral and cellular responses to SARS-CoV-2 in patients with B-cell haematological malignancies improve with successive vaccination. Br J Haematol 2023 (Online ahead of print). doi: 10.1111/bjh.18962.